Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status

Get up to date on best practices for assessing HER2 status and treating patients with HER2-low breast cancer with downloadable slides from a satellite symposium at SABCS 2022 an on-demand webcast and an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmaceuticals

Daiichi Sankyo, Inc.